A Real-Life Study of Deferasirox in Patients with Higher Risk Myelodysplastic Syndromes. (April 2017) - Musto, P.; Maurillo, L.; Simeon, V.; Poloni, A.; Finelli, C.; Balleari, E.; Ricco, A.; Rivellini, F.; Cortelezzi, A.; Tarantini, G.; Villani, O.; Breccia, M.; et al.